Skip to content
Umoja Biopharma
  • Our Company
    • Leadership
    • Board of Directors
    • Advisory Board
    • Investors
  • Our Science
    • Overview
    • Manufacturing
    • Partnerships
  • Our Pipeline
  • News + Resources
    • Press Releases
    • In The Media
    • Blog
    • White Papers
    • Presentations + Publications
  • Careers
  • Contact
  • Our Company
  • Our Science
    • Overview
    • Manufacturing
    • Partnerships
  • Our Pipeline
  • News + Resources
    • Press Releases
    • In The Media
    • Blog
    • White Papers
    • Presentations
  • Careers
  • Contact
Umoja Biopharma
  • Our Company
  • Our Science
    • Overview
    • Manufacturing
    • Partnerships
  • Our Pipeline
  • News + Resources
    • Press Releases
    • In The Media
    • Blog
    • White Papers
    • Presentations
  • Careers
  • Contact
  • Accessibility
  • Privacy Policy
  • Transparency in Coverage
  • Sitemap

Presentation

Potent in vivo CAR T cell generation and durable antitumor activity in preclinical models using VivoVec, a surface-engineered lentiviral vector platform

VivoVec lentiviral vector particles surface-engineered with T cell activating and co-stimulatory ligands enhance in vivo CAR T cell generation and antitumor activity

Synthetic Receptor Enabled Differentiation (ShRED), a novel platform for manufacturing of iPSC-derived cytotoxic innate lymphocytes for “off-the-shelf” cancer immunotherapies

In vivo generation of universal CAR T cells that mediate durable anti-tumor immunity through combinatorial targeting with bispecific small molecule adaptors

Engineering iPSCs with Synthetic Receptors to Drive Differentiation Compatible with Scale-Up

Posts navigation
1 2 … 4 Next Page →
CONTACT US
Umoja Biopharma
  • Our Company
  • Our Science
  • Manufacturing
  • Partnerships
  • Our Pipeline
  • Careers
  • Press Releases
  • In The Media
  • Blog
  • White Papers
  • Presentations

1616 Eastlake Ave E.
Suite 550
Seattle, WA 98102
info@umoja-biopharma.com

  • Accessibility
  • Privacy Policy
  • Transparency in Coverage
  • Sitemap

© 2023 Umoja Biopharma. All rights reserved.